Glaxosmithkline Pharmaceuticals consolidated net profit declines 3.94% in the December 2021 quarter

Sales rise 3.04% to Rs 815.92 crore

Net profit of Glaxosmithkline Pharmaceuticals declined 3.94% to Rs 150.35 crore in the quarter ended December 2021 as against Rs 156.51 crore during the previous quarter ended December 2020. Sales rose 3.04% to Rs 815.92 crore in the quarter ended December 2021 as against Rs 791.87 crore during the previous quarter ended December 2020. ParticularsQuarter EndedDec. 2021Dec. 2020% Var.Sales815.92791.87 3 OPM %24.2422.81 -PBDT219.62211.00 4 PBT201.75193.46 4 NP150.35156.51 -4

Powered by Capital Market - Live News